Related Experiment Video

Updated: Jun 1, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma

Regina Golan-Gerstl1, Michal Cohen, Asaf Shilo

  • 1Department of Biochemistry and Molecular Biology, the Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

Cancer Research
|May 19, 2011
PubMed

Insights

The splicing factor hnRNP A2/B1 is overexpressed in glioblastoma, acting as a novel oncogene. Targeting HNRNPA2B1 may offer new therapeutic strategies for glioblastoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Alternative splicing dysregulation is common in cancer, yet the role of splicing regulators remains unclear.
  • hnRNP A2/B1 (HNRNPA2B1) is a splicing factor implicated in cancer development.

Purpose of the Study:

  • To investigate the role of hnRNP A2/B1 in glioblastoma pathogenesis.
  • To determine if HNRNPA2B1 functions as a proto-oncogene in glioblastoma.

Main Methods:

  • Analyzed HNRNPA2B1 expression in glioblastoma patient samples.
  • Performed knockdown and overexpression studies in glioblastoma and immortal cell lines.
  • Utilized mouse xenograft models to assess tumor formation.
  • Identified downstream targets of HNRNPA2B1, including oncogenes and tumor suppressors.

Main Results:

  • HNRNPA2B1 is overexpressed in glioblastomas and correlates with poor prognosis.
  • HNRNPA2B1 knockdown inhibits glioblastoma cell tumorigenicity in vivo.
  • Overexpression of HNRNPA2B1 induces malignant transformation in immortal cells.
  • HNRNPA2B1 regulates key genes including c-FLIP, BIN1, WWOX, and the proto-oncogene RON.
  • RON is identified as a mediator of HNRNPA2B1's oncogenic activity.

Conclusions:

  • HNRNPA2B1 acts as a novel oncogene in glioblastoma.
  • HNRNPA2B1 is a potential therapeutic target for glioblastoma.

More Related Videos

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells06:48

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells

Published on: June 16, 2022

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...